Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

DSpace Repository

Show simple item record

dc.contributor.author Sipos, Bence
dc.date.accessioned 2023-05-22T10:04:10Z
dc.date.available 2023-05-22T10:04:10Z
dc.date.issued 2022
dc.identifier.issn 2211-3428
dc.identifier.uri http://hdl.handle.net/10900/141302
dc.language.iso en de_DE
dc.publisher Springer de_DE
dc.relation.uri http://dx.doi.org/10.1007/s13402-022-00727-z de_DE
dc.subject.ddc 570 de_DE
dc.subject.ddc 610 de_DE
dc.title Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy de_DE
dc.type Article de_DE
utue.quellen.id 20230202000000_00819
utue.publikation.seiten 1401-1419 de_DE
utue.personen.roh Viol, Fabrice
utue.personen.roh Sipos, Bence
utue.personen.roh Fahl, Martina
utue.personen.roh Clauditz, Till S.
utue.personen.roh Amin, Tania
utue.personen.roh Kriegs, Malte
utue.personen.roh Nieser, Maike
utue.personen.roh Izbicki, Jakob R.
utue.personen.roh Huber, Samuel
utue.personen.roh Lohse, Ansgar W.
utue.personen.roh Schrader, Joerg
dcterms.isPartOf.ZSTitelID Cellular Oncology de_DE
dcterms.isPartOf.ZS-Issue 6 de_DE
dcterms.isPartOf.ZS-Volume 45 de_DE
utue.fakultaet 04 Medizinische Fakultät de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record